Advaxis Inc (OTCBB - OTCQB:ADXS)
| 0.039 Data as of Jun 19 |  -0.0001 / -0.26%Today’s Change | 0.03 Today|||52-Week Range 0.16 | +30.00% Year-to-Date |
Latest ADXS News | Press Releases
No recent news for Advaxis Inc.
Today’s Trading
| Previous close | 0.04 |
| Today’s open | 0.04 |
| Day’s range | -- - -- |
| Volume | 1,232,717 |
| Average volume (3 months) | 2,026,256 |
| Market cap | $23.3M |
| Dividend yield | -- |
Data as of 3:36pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | 0.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ASTMAastrom Biosciences ... | -0.01 | -2.54% |
| ELTPElite Pharmaceutical... | +0.00 | +0.87% |
| PTNPalatin Technologies... | -0.01 | -1.12% |
| PRPHProPhase Labs Inc | +0.04 | +2.58% |
Data as of 3:59pm ET, 06/19/2013
Financials
| Last reporting date | June 30, 2010 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$12.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Thomas A. Moore |
Chief Financial Officer, Secretary & Senior VP Mark J. Rosenblum, CPA |
Corporate headquarters Princeton, New Jersey |
Forecasts
